𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia

✍ Scribed by Cristina Carvalho; Sónia C. Correia; Renato X. Santos; Susana Cardoso; Paula I. Moreira; Timothy A. Clark; Xiongwei Zhu; Mark A. Smith; George Perry


Publisher
Springer US
Year
2009
Tongue
English
Weight
201 KB
Volume
41
Category
Article
ISSN
0145-479X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Role of mitochondrial dysfunction in Alz
✍ Rudy Castellani; Keisuke Hirai; Gjumrakch Aliev; Kelly L. Drew; Akihiko Nunomura 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract Abnormalities in mitochondrial function relate to the spectrum of pathological changes seen in Alzheimer's disease. Here we review the causes and consequences of mitochondrial disturbances in Alzheimer's disease as well as how this information might impact on therapeutic approaches to t

Crosstalk of hypoxia-mediated signaling
✍ Qunzhou Zhang; Yidi Wu; Cindy H. Chau; David K. Ann; Charles N. Bertolami; Anh D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Keloids are skin fibrotic conditions characterized by an excess accumulation of extracellular matrix (ECM) components secondary to trauma or surgical injuries. Previous studies have shown that plasminogen activator inhibitor-1 (PAI-1) can be upregulated by hypoxia and may contribute to keloid pathog

Role of the SNK-SPAR pathway in the deve
✍ Xiaoyang Gong; Xiaoguang Lu; Libin Zhan; Hua Sui; Xin Qi; Zhenghong Ji; Xinping 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

## Abstract Alzheimer's disease (AD) is characterized by the presence of senile plaques and neurofibrillary tangles in the brain. The beta‐amyloid peptide (Aβ) is the primary constituent of the senile plaques, and has been proposed to be a key contributor to the neurodegeneration observed in AD. Th